The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 11, 2018

Filed:

Apr. 29, 2016
Applicants:

Emory University, Atlanta, GA (US);

Children's Healthcare of Atlanta, Inc., Atlanta, GA (US);

Inventors:

Baozhong Wang, Dultuh, GA (US);

Richard W. Compans, Atlanta, GA (US);

Jacques Galipeau, Atlanta, GA (US);

Jiusheng Deng, Snellville, GA (US);

Assignees:

Emory University, Atlanta, GA (US);

Children's Healthcare of Atlanta, Inc., Atlanta, GA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/54 (2006.01); C07K 14/535 (2006.01); C07K 14/005 (2006.01); C12N 5/10 (2006.01); C12N 15/63 (2006.01); C12N 15/79 (2006.01); C07K 14/705 (2006.01); C07K 14/435 (2006.01); A61K 39/12 (2006.01); C07K 16/10 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/5406 (2013.01); A61K 39/12 (2013.01); C07K 14/005 (2013.01); C07K 14/435 (2013.01); C07K 14/535 (2013.01); C07K 14/70596 (2013.01); C07K 16/1063 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/543 (2013.01); A61K 2039/55522 (2013.01); A61K 2039/55527 (2013.01); A61K 2039/575 (2013.01); C07K 2317/33 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2319/035 (2013.01); C07K 2319/912 (2013.01); C12N 15/63 (2013.01); C12N 15/79 (2013.01); C12N 2740/16023 (2013.01); C12N 2740/16034 (2013.01); C12N 2740/16122 (2013.01); C12N 2740/16134 (2013.01); C12N 2740/16222 (2013.01);
Abstract

This disclosure relates to a GM-CSF and IL-4 conjugate fused to a glycolipid (GPI)-anchoring sequence that is incorporated into chimeric virus-like particles (VLPs) enriched with a viral protein, e.g., viral envelope protein or HIV envelope protein. In certain embodiments, the disclosure relates to methods of immunization with the chimeric VLPs disclosed herein. In certain embodiments, the disclosure relates to methods of immunization with disclosed HIV antigen containing VLPs through an intramuscular priming-intranasal boosting immunization route.


Find Patent Forward Citations

Loading…